R. K. Polyclinic & Diagnostic Centre Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 17-12-2024
- Paid Up Capital ₹ 8.00 M
as on 17-12-2024
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.83 Cr
as on 17-12-2024
- Revenue 60.99%
(FY 2021)
- Profit 82.85%
(FY 2021)
- Ebitda 78.48%
(FY 2021)
- Net Worth 12.95%
(FY 2021)
- Total Assets 28.83%
(FY 2021)
About R. K. Polyclinic & Diagnostic Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹3.83 Cr.
Deepak Tripathi and Khushboo Kumari serve as directors at the Company.
- CIN/LLPIN
U74999JH2017PTC009683
- Company No.
009683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jharkhand
Industry
Company Details
- Location
Ranchi, Jharkhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at R. K. Polyclinic & Diagnostic Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Tripathi  | Director | 27-Feb-2017 | Current |
| Khushboo Kumari | Director | 27-Feb-2017 | Current |
Financial Performance of R. K. Polyclinic & Diagnostic Centre.
R. K. Polyclinic & Diagnostic Centre Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 60.99% increase. The company also saw a substantial improvement in profitability, with a 82.85% increase in profit. The company's net worth Soared by an impressive increase of 12.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of R. K. Polyclinic & Diagnostic Centre?
In 2021, R. K. Polyclinic & Diagnostic Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Apr 2023 | ₹8.50 M | Open |
Axis Bank Limited Creation Date: 06 Jun 2022 | ₹7.00 M | Open |
Hdfc Bank Limited Creation Date: 30 Apr 2022 | ₹2.28 Cr | Open |
How Many Employees Work at R. K. Polyclinic & Diagnostic Centre?
Unlock and access historical data on people associated with R. K. Polyclinic & Diagnostic Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of R. K. Polyclinic & Diagnostic Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped R. K. Polyclinic & Diagnostic Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
